Association of novel single nucleotide polymorphisms in the calcium channel α1 subunit gene (Cav1.1) and thyrotoxic periodic paralysis

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1340-1345

  Kung, Annie W C ^a   Lau, K S ^a   Fong, G C Y ^a   Chan, Vivian ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL; THYROID HORMONE;

ADULT; ARTICLE; BINDING AFFINITY; CHROMOSOME 1; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; GRAVES DISEASE; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

5' FLANKING REGION; ADULT; CALCIUM CHANNELS; CHROMOSOMES, HUMAN, PAIR 1; GENOTYPE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUSCLE PROTEINS; PARALYSES, FAMILIAL PERIODIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; SHAW POTASSIUM CHANNELS; SODIUM CHANNELS; THYROTOXICOSIS;

EID: 1642365758     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030924     Document Type: Article

References (33)

1. Ober KP 1992 Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine 71:109-120
2. Papadopoulos KI, Diep T, Cleland B, Lunn NW 1997 Thyrotoxic periodic paralysis: report of three cases and review of the literature. J Intern Med 241:521-524
3. Kung AWC 2002 Thyrotoxic periodic paralysis. In: Wass JAH, Shalet SM, eds. Oxford textbook of endocrinology and diabetes. Oxford, UK: Oxford University Press; 427-429
4. McFadzean AJS, Yeung R 1967 Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J 1:451-455
5. Pearson CM, Kalyanaraman K 1972 The periodic paralysis. In: Stanbury JB, Wynagaarden JB, Fredrickson DS, eds. The metabolic basis of inherited disease. 3rd ed. New York: McGraw-Hill Book Company; 1181
6. Griggs RC, Ptáèek LJ 1992 The periodic paralyses. Hosp Pract 27:123-137
7. Jurkat-Rott K, Lehmann-Hom F, Elbaz A, Heine R, Gregg RG, Hogan K, Powers PA, Lapie P, Vale-Santos JE, Weissenbach J, Fontaine B 1994 A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 3:1415-1419
8. Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G, Bradley P, Leppert MF 1994 Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863-868
9. Elbaz A, Vale-Santos J, Jurkat-Rott K, Lapie P, Ophoff RA, Bady B, Links TP, Piussan C, Vila A, Monnier N, Padberg GW, Abe K, Feingold N, Guimaraes J, Wintzen AR, van der Hoeven JH, Saudubray JM, Grunfeld JP, Lenoir G, Nivet H, Echenne B, Frants RR, Fardeau M, Lehmann-Horn F, Fontaine B 1995 Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 56:374-380
10. Sillen A, Sorensen T, Kantola I, Friis ML, Gustavson KH, Wadelius C 1997 Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am J Med Genet 69:102-106
11. Fouad G, Dalakas M, Servidei S, Mendell JR, Van den Bergh P, Angelini C, Alerson K, Griggs RC, Tawil R, Gregg R, Hogan K, Powers PA, Weinberg N, Malonee W, Ptacek LJ 1997 Genotype-phenotype correlations of DHP receptor α 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord 7:33-38
12. Bulman DE, Scoggan KA, van Oene MD, Nicolle MW, Hahn AF, Tollar LL, Ebers GC 1999 A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53:1932-1936
13. Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, Lerche H, Nicolle SF, Vale-Santos JE, Chaurean D, Fontaine B, Lehmann-Horn F 2000 Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97:9549-9554
14. Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, Goldstein SA 2001 MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104:217-231
15. Drouet B, Garcia L, Simon-Chazottes D, Mattei MG, Guenet JL, Schwartz A, Varadi G, Pincon-Raymond M 1993 The gene coding for the α-1 subunit of the skeletal dihydropyridine receptor maps to mouse chromosome 1 and human 1q32. Mamm Genome 4:499-503
16. Hogan K, Gregg RG, Powers PA 1996 The structure of the gene encoding the human skeletal muscle α1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics 31:392-394
17. Dias Da Silva MR, Cerutti JM, Arnaldi LA, Maciel RM 2002 A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 87:4881-4884
18. Curfman GD, Crowley TJ, Smith TW 1977 Thyroid-induced alterations in myocardial sodium-potassium-activated adenosine triphosphatase, monovalent cation active transport, and cardiac glycoside binding. J Clin Invest 59: 586-590
19. Marx A, Ruppersberg JP, Pietrzyk C, Rudel R 1989 Thyrotoxic periodic paralysis and the sodium/potassium pump. Muscle Nerve 12:810-815
20. Lapie P, Lory P, Fontaine B 1997 Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord 7:234-240
21. Links TP, Smit AJ, Molenaar WM, Zwarts MJ, Oosterhuis HJ 1994 Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects. J Neurol Sci 122:33-43
22. v1.1) are not associated with thyrotoxic periodic paralysis. Clin Endocrinol (Oxf) 56:367-375
23. Tricarico D, Servidei S, Tonali P, Jurkat-Rott K, Camerino DC 1999 Impairment of skeletal muscle adenosine triphosphate-sensitive K channels in patients with hypokalemic periodic paralysis. J Clin Invest 103:675-682
24. Kim HS, Crone DE, Sprung CN, Tillman JB, Force WR, Crew MO, Mote PL, Spindler SR 1992 Positive and negative thyroid hormone response elements are composed of strong and weak half-sites 10 nucleotides in length. Mol Endocrinol 6:1489-1501
25. Carr FE, Kaseem LL, Wong NC 1992 Thyroid hormone inhibits thyrotropin gene expression via a position-independent negative L-triiodothyronine- responsive element. J Biol Chem 267:18689-18694
26. Bigler J, Eisenman RN 1995 Novel location and function of a thyroid hormone responsive element. EMBO J 14:5710-5723
27. Manoukian MA, Foote JA, Crapo LM 1999 Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 159:601-606
28. Layzer RB 1982 Periodic paralysis and the sodium-potassium pump. Ann Neurol 11:547-552
29. +-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci (Lond) 72:171-179
30. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R 1991 In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. Br Med J 303:1096-1099
31. Clausen T, Everts ME 1989 Regulation of Na,K-pump in skeletal muscle. Kidney Int 35:1-13 (Review)
32. Lee KO, Taylor EA, Oh VMS, Cheah JS, Aw SE 1991 Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet 337:1063-1064
33. Hofmann WW, Adornato BT, Reich H 1983 The relationship of insulin receptors to hypokalemic periodic paralysis. Muscle Nerve 6:48-51